Articles with public access mandates - Carlo CroceLearn more
Not available anywhere: 19
MicroRNA and cancer–a brief overview
M Acunzo, G Romano, D Wernicke, CM Croce
Advances in biological regulation 57, 1-9, 2015
Mandates: US National Institutes of Health
Clinical applications for microRNAs in cancer
SP Nana‐Sinkam, CM Croce
Clinical Pharmacology & Therapeutics 93 (1), 98-104, 2013
Mandates: US National Institutes of Health
Interplay between microRNAs and the epigenetic machinery: an intricate network
MV Iorio, C Piovan, CM Croce
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799 (10-12 …, 2010
Mandates: US National Institutes of Health
Micro RNA s play a central role in molecular dysfunctions linking inflammation with cancer
E Tili, JJ Michaille, CM Croce
Immunological reviews 253 (1), 167-184, 2013
Mandates: US National Institutes of Health
MicroRNAs as therapeutic targets in cancer
SP Nana-Sinkam, CM Croce
Translational Research 157 (4), 216-225, 2011
Mandates: US National Institutes of Health
LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis
JY Lee, JH Park, HJ Choi, HY Won, HS Joo, DH Shin, MK Park, B Han, ...
Oncogene 36 (39), 5512-5521, 2017
Mandates: US National Institutes of Health
Atheroprotective mechanisms of shear stress-regulated microRNAs
RA Boon, E Hergenreider, S Dimmeler
Thrombosis and haemostasis 108 (10), 616-620, 2012
Mandates: German Research Foundation
MicroRNAs as anti-cancer therapy
M Garofalo, G Di Leva, C M Croce
Current pharmaceutical design 20 (33), 5328-5335, 2014
Mandates: Cancer Research UK
MicroRNA and ER stress in cancer
T Kim, CM Croce
Seminars in cancer biology 75, 3-14, 2021
Mandates: US National Institutes of Health, National Natural Science Foundation of China
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias
G Marcucci, K Mrózek, MD Radmacher, CD Bloomfield, CM Croce
Best practice & research Clinical haematology 22 (2), 239-248, 2009
Mandates: US National Institutes of Health
Friend or Foe: MicroRNAs in the p53 network
Z Luo, R Cui, E Tili, C Croce
Cancer letters 419, 96-102, 2018
Mandates: US National Institutes of Health
Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia
M Acunzo, CM Croce
Clinical chemistry 62 (4), 655-656, 2016
Mandates: US National Institutes of Health
Oncosuppressor proteins of fragile sites are reduced in cervical cancer
E Giarnieri, N Zanesi, A Bottoni, M Alderisio, A Lukic, A Vecchione, ...
Cancer letters 289 (1), 40-45, 2010
Mandates: US National Institutes of Health
ncRNA editing: functional characterization and computational resources
G Nigita, GP Marceca, L Tomasello, R Distefano, F Calore, D Veneziano, ...
Computational Biology of Non-Coding RNA: Methods and Protocols, 133-174, 2019
Mandates: US National Institutes of Health
Novel insights in molecular mechanisms of CLL
N Zanesi, V Balatti, A Bottoni, C M Croce, Y Pekarsky
Current pharmaceutical design 18 (23), 3363-3372, 2012
Mandates: US National Institutes of Health
RNA nanoparticle orientation to control ligand display on exosomes for cancer regression
DW Binzel, F Pi, TJ Lee, Z Li, M Sun, P Rychahou, H Li, F Haque, S Wang, ...
Journal of Extracellular Vesicles 7, 194-194, 2018
Mandates: US National Institutes of Health
A NOVEL THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER THROUGH INHIBITION OF ONCOGENIC MICRORNAS: MP83-15
T Sheetz, D Palmieri, V Coppola, A Tessari, J Mills, A Braddom, E Reese, ...
Journal of Urology 197 (4), e1111-e1112, 2017
Mandates: US National Institutes of Health
Molecular pathogenesis
A Bottoni, CM Croce, GA Calin
Chronic Lymphocytic Leukemia, 51-60, 2008
Mandates: US National Institutes of Health
microRNAs in Cell Biology and Diseases
M Fabbri, CM Croce, GA Calin
Epigenetics in Biology and Medicine, 105-130, 2008
Mandates: US National Institutes of Health
Available somewhere: 410
Causes and consequences of microRNA dysregulation in cancer
CM Croce
Nature reviews genetics 10 (10), 704-714, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program